620 related articles for article (PubMed ID: 32430502)
21. Progressive telomere shortening in aplastic anemia.
Ball SE; Gibson FM; Rizzo S; Tooze JA; Marsh JC; Gordon-Smith EC
Blood; 1998 May; 91(10):3582-92. PubMed ID: 9572992
[TBL] [Abstract][Full Text] [Related]
22. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
Shichishima T; Noji H
Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
[TBL] [Abstract][Full Text] [Related]
23. [Clonal chromosomal aberrations in patients with aplastic anemia at the disease onset and transformation].
Ol'shanskaia IuV; Mikhaĭlova EA; Domracheva EV; Udovichenko AI; Davidian IuR; Vodinskaia LA; Zakharova AV; Kokhno AV; Kaplanskaia IB; Tikhonova LIu; Tsvetaeva NV; Parovichnikova EN; Savchenko VG
Ter Arkh; 2006; 78(7):31-4, 36-7. PubMed ID: 16944748
[TBL] [Abstract][Full Text] [Related]
24. Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome.
Durrani J; Maciejewski JP
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):97-104. PubMed ID: 31808900
[TBL] [Abstract][Full Text] [Related]
25. Analysis of abnormal clones by the fluorescent aerolysin method in paroxysmal nocturnal haemoglobinuria and other marrow disorders.
Agarwal R; Chapple P; Brown M; Szer J; Juneja S
Int J Lab Hematol; 2015 Feb; 37(1):14-21. PubMed ID: 24702736
[TBL] [Abstract][Full Text] [Related]
26. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
[TBL] [Abstract][Full Text] [Related]
27. Screening for paroxysmal nocturnal hemoglobinuria (PNH) clone in Egyptian children with aplastic anemia.
Rizk S; Ibrahim IY; Mansour IM; Kandil D
J Trop Pediatr; 2002 Jun; 48(3):132-7. PubMed ID: 12164595
[TBL] [Abstract][Full Text] [Related]
28. Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia.
Dumitriu B; Feng X; Townsley DM; Ueda Y; Yoshizato T; Calado RT; Yang Y; Wakabayashi Y; Kajigaya S; Ogawa S; Zhu J; Young NS
Blood; 2015 Jan; 125(4):706-9. PubMed ID: 25406353
[TBL] [Abstract][Full Text] [Related]
29. Introduction to Acquired and Inherited Bone Marrow Failure.
Sieff CA
Hematol Oncol Clin North Am; 2018 Aug; 32(4):569-580. PubMed ID: 30047411
[TBL] [Abstract][Full Text] [Related]
30. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.
Maciejewski JP; Follmann D; Nakamura R; Saunthararajah Y; Rivera CE; Simonis T; Brown KE; Barrett JA; Young NS
Blood; 2001 Dec; 98(13):3513-9. PubMed ID: 11739151
[TBL] [Abstract][Full Text] [Related]
31. The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH): a high incidence of multiple mutations and evidence of a mutational hot spot.
Mortazavi Y; Merk B; McIntosh J; Marsh JC; Schrezenmeier H; Rutherford TR;
Blood; 2003 Apr; 101(7):2833-41. PubMed ID: 12424196
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children.
Kojima S; Ohara A; Tsuchida M; Kudoh T; Hanada R; Okimoto Y; Kaneko T; Takano T; Ikuta K; Tsukimoto I;
Blood; 2002 Aug; 100(3):786-90. PubMed ID: 12130487
[TBL] [Abstract][Full Text] [Related]
33. Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria.
Gurnari C; Pagliuca S; Prata PH; Galimard JE; Catto LFB; Larcher L; Sebert M; Allain V; Patel BJ; Durmaz A; Pinto AL; Inacio MCB; Hernandez L; Dhedin N; Caillat-Zucman S; Clappier E; Sicre de Fontbrune F; Voso MT; Visconte V; Peffault de Latour R; Soulier J; Calado RT; Socié G; Maciejewski JP
J Clin Oncol; 2023 Jan; 41(1):132-142. PubMed ID: 36054881
[TBL] [Abstract][Full Text] [Related]
34. The Risk of Clonal Evolution of Granulocyte Colony-Stimulating Factor for Acquired Aplastic Anemia: A Systematic Review and Meta-Analysis.
Ding SX; Chen T; Wang T; Liu CY; Lu WL; Fu R
Acta Haematol; 2018; 140(3):141-145. PubMed ID: 30253387
[TBL] [Abstract][Full Text] [Related]
35. Myelodysplasia following aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome after treatment with immunosuppression and G-CSF: evidence for the emergence of a separate clone.
Jin JY; Tooze JA; Marsh JC; Matthey F; Gordon-Smith EC
Br J Haematol; 1996 Sep; 94(3):510-2. PubMed ID: 8790151
[TBL] [Abstract][Full Text] [Related]
36. Acquired somatic mutations of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) in preleukemic disorders.
Chotirat S; Thongnoppakhun W; Wanachiwanawin W; Auewarakul CU
Blood Cells Mol Dis; 2015 Mar; 54(3):286-91. PubMed ID: 25486927
[TBL] [Abstract][Full Text] [Related]
37. Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia.
Savage SA; Dufour C
Semin Hematol; 2017 Apr; 54(2):105-114. PubMed ID: 28637614
[TBL] [Abstract][Full Text] [Related]
38. [Clonal hematopoiesis in aplastic anemia].
Makishima H
Rinsho Ketsueki; 2018; 59(10):1962-1968. PubMed ID: 30305498
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome.
Horikawa K; Nakakuma H; Kawaguchi T; Iwamoto N; Nagakura S; Kagimoto T; Takatsuki K
Blood; 1997 Oct; 90(7):2716-22. PubMed ID: 9326238
[TBL] [Abstract][Full Text] [Related]
40. High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome.
Okamoto M; Shichishima T; Noji H; Ikeda K; Nakamura A; Akutsu K; Maruyama Y
Leukemia; 2006 Apr; 20(4):627-34. PubMed ID: 16467865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
